LongeVC Named Finalist for VC Firm of the Year at the 2026 European Lifestars Awards

LongeVC has been named a finalist in the VC Firm of the Year category at the 2026 European Lifestars Awards, the annual awards recognizing the executives, investors, and companies shaping European life sciences over the past 12 months.

The shortlist places LongeVC alongside established European biotech investors, including Sofinnova Partners, Forbion, Medicxi, Novo Holdings, HealthCap, Andera Partners, HTGF, Jeito Capital, and Kurma Partners, a strong signal that longevity-focused investing has earned its place in the mainstream of European life science venture capital.

There is a second reason to celebrate this year's list. Ola Wlodek, CEO of our portfolio company Constructive Bio, is a finalist in two categories: CEO of the Year and Woman-Led Business of the Year. Constructive Bio is reengineering genomes to expand what biology can build, and Ola's double shortlisting reflects the caliber of leadership behind that work.

Winners will be announced at the awards ceremony in London on November 16, 2026. The full list of finalists is available on the European Lifestars Awards website.